| 摘要 |
The invention relates to the use, especially in vitro, of one or more nucleic acids, the transcription product(s) thereof and/or the translation product(s) thereof for a process. Said process is selected from the group including angiogenesis, neovascularization, transmyocardial revascularization, wound healing, wound bed angiogenesis, epithelization and healing in of dental and bone implants. The nucleic acid(s) is/are selected from the group including the genes for high mobility group proteins. |
